Current Portfolio
T-Knife
T-knife is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR).
Key Facts
- Sector
Life Sciences
- Country
Germany
- Fund
LSP 6
- Entry
2021
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.